<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-02-01" modified="2020-10-07" version="239">
<accession>Q07955</accession>
<accession>B2R6Z7</accession>
<accession>D3DTZ3</accession>
<accession>Q13809</accession>
<name>SRSF1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Serine/arginine-rich splicing factor 1</fullName>
</recommendedName>
<alternativeName>
<fullName>Alternative-splicing factor 1</fullName>
<shortName>ASF-1</shortName>
</alternativeName>
<alternativeName>
<fullName>Splicing factor, arginine/serine-rich 1</fullName>
</alternativeName>
<alternativeName>
<fullName>pre-mRNA-splicing factor SF2, P33 subunit</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">SRSF1</name>
<name type="synonym">ASF</name>
<name type="synonym">SF2</name>
<name type="synonym">SF2P33</name>
<name type="synonym">SFRS1</name>
<name type="ORF">OK/SW-cl.3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Cell" volume="66" first="373" last="382">
<title>Primary structure of the human splicing factor ASF reveals similarities with Drosophila regulators.</title>
<authorList>
<person name="Ge H."/>
<person name="Zuo P."/>
<person name="Manley J.L."/>
</authorList>
<dbReference type="PubMed" id="1855257"/>
<dbReference type="DOI" id="10.1016/0092-8674(91)90626-a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ASF-1 AND ASF-2)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1991" name="Cell" volume="66" first="383" last="394">
<title>Functional expression of cloned human splicing factor SF2: homology to RNA-binding proteins, U1 70K, and Drosophila splicing regulators.</title>
<authorList>
<person name="Krainer A.R."/>
<person name="Mayeda A."/>
<person name="Kozak D."/>
<person name="Binns G."/>
</authorList>
<dbReference type="PubMed" id="1830244"/>
<dbReference type="DOI" id="10.1016/0092-8674(91)90627-b"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ASF-1)</scope>
<scope>PROTEIN SEQUENCE OF 144-161 AND 167-175</scope>
</reference>
<reference key="3">
<citation type="submission" date="2001-05" db="EMBL/GenBank/DDBJ databases">
<title>Identification of immuno-peptidmics that are recognized by tumor-reactive CTL generated from TIL of colon cancer patients.</title>
<authorList>
<person name="Shichijo S."/>
<person name="Itoh K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ASF-1)</scope>
<source>
<tissue>Colon adenocarcinoma</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ASF-1)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS ASF-1 AND ASF-3)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Lubec G."/>
<person name="Chen W.-Q."/>
<person name="Sun Y."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 18-28; 31-38; 52-65; 75-83; 123-138 AND 143-164</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Fetal brain cortex</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1992" name="Genes Dev." volume="6" first="837" last="847">
<title>SR proteins: a conserved family of pre-mRNA splicing factors.</title>
<authorList>
<person name="Zahler A.M."/>
<person name="Lane W.S."/>
<person name="Stolk J.A."/>
<person name="Roth M.B."/>
</authorList>
<dbReference type="PubMed" id="1577277"/>
<dbReference type="DOI" id="10.1101/gad.6.5.837"/>
</citation>
<scope>PROTEIN SEQUENCE OF 123-140</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1992" name="Proc. Natl. Acad. Sci. U.S.A." volume="89" first="1301" last="1304">
<title>Two members of a conserved family of nuclear phosphoproteins are involved in pre-mRNA splicing.</title>
<authorList>
<person name="Mayeda A."/>
<person name="Zahler A.M."/>
<person name="Krainer A.R."/>
<person name="Roth M.B."/>
</authorList>
<dbReference type="PubMed" id="1741384"/>
<dbReference type="DOI" id="10.1073/pnas.89.4.1301"/>
</citation>
<scope>CHARACTERIZATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1993" name="Cell" volume="75" first="1061" last="1070">
<title>Specific interactions between proteins implicated in splice site selection and regulated alternative splicing.</title>
<authorList>
<person name="Wu J.Y."/>
<person name="Maniatis T."/>
</authorList>
<dbReference type="PubMed" id="8261509"/>
<dbReference type="DOI" id="10.1016/0092-8674(93)90316-i"/>
</citation>
<scope>INTERACTION IN SPLICEOSOME ASSEMBLY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1993" name="EMBO J." volume="12" first="4727" last="4737">
<title>Functional domains of the human splicing factor ASF/SF2.</title>
<authorList>
<person name="Zuo P."/>
<person name="Manley J.L."/>
</authorList>
<dbReference type="PubMed" id="8223481"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1993.tb06161.x"/>
</citation>
<scope>MUTAGENESIS</scope>
<scope>CHARACTERIZATION OF FUNCTIONAL DOMAINS</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1994" name="Nature" volume="368" first="119" last="124">
<title>Protein-protein interactions and 5'-splice-site recognition in mammalian mRNA precursors.</title>
<authorList>
<person name="Kohtz J.D."/>
<person name="Jamison S.F."/>
<person name="Will C.L."/>
<person name="Zuo P."/>
<person name="Luehrmann R."/>
<person name="Garcia-Blanco M.A."/>
<person name="Manley J.L."/>
</authorList>
<dbReference type="PubMed" id="8139654"/>
<dbReference type="DOI" id="10.1038/368119a0"/>
</citation>
<scope>FUNCTION IN RECRUITMENT OF U1-70K TO PRE-MRNA</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="3363" last="3367">
<title>The human splicing factor ASF/SF2 can specifically recognize pre-mRNA 5' splice sites.</title>
<authorList>
<person name="Zuo P."/>
<person name="Manley J.L."/>
</authorList>
<dbReference type="PubMed" id="7512732"/>
<dbReference type="DOI" id="10.1073/pnas.91.8.3363"/>
</citation>
<scope>RECOGNITION OF PRE-MRNA 5'SPLICE SITES</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1995" name="EMBO J." volume="14" first="3540" last="3551">
<title>The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities.</title>
<authorList>
<person name="Tacke R."/>
<person name="Manley J.L."/>
</authorList>
<dbReference type="PubMed" id="7543047"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1995.tb07360.x"/>
</citation>
<scope>RNA-BINDING SPECIFICITY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1997" name="Nature" volume="388" first="397" last="400">
<title>A protein related to splicing factor U2AF35 that interacts with U2AF65 and SR proteins in splicing of pre-mRNA.</title>
<authorList>
<person name="Tronchere H."/>
<person name="Wang J."/>
<person name="Fu X.D."/>
</authorList>
<dbReference type="PubMed" id="9237760"/>
<dbReference type="DOI" id="10.1038/41137"/>
</citation>
<scope>INTERACTION WITH ZRSR2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1998" name="Genes Dev." volume="12" first="55" last="66">
<title>A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm.</title>
<authorList>
<person name="Caceres J.F."/>
<person name="Screaton G.R."/>
<person name="Krainer A.R."/>
</authorList>
<dbReference type="PubMed" id="9420331"/>
<dbReference type="DOI" id="10.1101/gad.12.1.55"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF PHE-162 AND PHE-180</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1998" name="Mol. Cell" volume="2" first="751" last="759">
<title>A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2.</title>
<authorList>
<person name="Ge H."/>
<person name="Si Y."/>
<person name="Wolffe A.P."/>
</authorList>
<dbReference type="PubMed" id="9885563"/>
<dbReference type="DOI" id="10.1016/s1097-2765(00)80290-7"/>
</citation>
<scope>INTERACTION WITH PSIP1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1998" name="Nucleic Acids Res." volume="26" first="3542" last="3549">
<title>SAF-B couples transcription and pre-mRNA splicing to SAR/MAR elements.</title>
<authorList>
<person name="Nayler O."/>
<person name="Straetling W."/>
<person name="Bourquin J.-P."/>
<person name="Stagljar I."/>
<person name="Lindemann L."/>
<person name="Jasper H."/>
<person name="Hartmann A.M."/>
<person name="Fackelmeyer F.O."/>
<person name="Ullrich A."/>
<person name="Stamm S."/>
</authorList>
<dbReference type="PubMed" id="9671816"/>
<dbReference type="DOI" id="10.1093/nar/26.15.3542"/>
</citation>
<scope>INTERACTION WITH SAFB/SAFB1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="3049" last="3057">
<title>Identification and characterization of a novel serine-arginine-rich splicing regulatory protein.</title>
<authorList>
<person name="Barnard D.C."/>
<person name="Patton J.G."/>
</authorList>
<dbReference type="PubMed" id="10757789"/>
<dbReference type="DOI" id="10.1128/mcb.20.9.3049-3057.2000"/>
</citation>
<scope>INTERACTION WITH SREK1</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="6871" last="6882">
<title>Nuclear export and retention signals in the RS domain of SR proteins.</title>
<authorList>
<person name="Cazalla D."/>
<person name="Zhu J."/>
<person name="Manche L."/>
<person name="Huber E."/>
<person name="Krainer A.R."/>
<person name="Caceres J.F."/>
</authorList>
<dbReference type="PubMed" id="12215544"/>
<dbReference type="DOI" id="10.1128/mcb.22.19.6871-6882.2002"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="RNA" volume="8" first="426" last="439">
<title>Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis.</title>
<authorList>
<person name="Jurica M.S."/>
<person name="Licklider L.J."/>
<person name="Gygi S.P."/>
<person name="Grigorieff N."/>
<person name="Moore M.J."/>
</authorList>
<dbReference type="PubMed" id="11991638"/>
<dbReference type="DOI" id="10.1017/s1355838202021088"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN THE SPLICEOSOMAL C COMPLEX</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="Mol. Cell" volume="11" first="837" last="843">
<title>SR splicing factors serve as adapter proteins for TAP-dependent mRNA export.</title>
<authorList>
<person name="Huang Y."/>
<person name="Gattoni R."/>
<person name="Stevenin J."/>
<person name="Steitz J.A."/>
</authorList>
<dbReference type="PubMed" id="12667464"/>
<dbReference type="DOI" id="10.1016/s1097-2765(03)00089-3"/>
</citation>
<scope>INTERACTION WITH NXF1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="12601" last="12606">
<title>Processive phosphorylation of alternative splicing factor/splicing factor 2.</title>
<authorList>
<person name="Aubol B.E."/>
<person name="Chakrabarti S."/>
<person name="Ngo J."/>
<person name="Shaffer J."/>
<person name="Nolen B."/>
<person name="Fu X.-D."/>
<person name="Ghosh G."/>
<person name="Adams J.A."/>
</authorList>
<dbReference type="PubMed" id="14555757"/>
<dbReference type="DOI" id="10.1073/pnas.1635129100"/>
</citation>
<scope>PHOSPHORYLATION AT SERINE RESIDUES</scope>
<scope>INTERACTION WITH SRPK1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="2969" last="2980">
<title>A novel SR-related protein is required for the second step of pre-mRNA splicing.</title>
<authorList>
<person name="Cazalla D."/>
<person name="Newton K."/>
<person name="Caceres J.F."/>
</authorList>
<dbReference type="PubMed" id="15798186"/>
<dbReference type="DOI" id="10.1128/mcb.25.8.2969-2980.2005"/>
</citation>
<scope>INTERACTION WITH RSRC1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="7721" last="7732">
<title>Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: influence of cyclin L isoforms on splice site selection.</title>
<authorList>
<person name="Loyer P."/>
<person name="Trembley J.H."/>
<person name="Grenet J.A."/>
<person name="Busson A."/>
<person name="Corlu A."/>
<person name="Zhao W."/>
<person name="Kocak M."/>
<person name="Kidd V.J."/>
<person name="Lahti J.M."/>
</authorList>
<dbReference type="PubMed" id="18216018"/>
<dbReference type="DOI" id="10.1074/jbc.m708188200"/>
</citation>
<scope>INTERACTION WITH CCNL1; CCNL2 AND CDK11B</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="J. Mol. Biol." volume="376" first="55" last="68">
<title>Ordered multi-site phosphorylation of the splicing factor ASF/SF2 by SRPK1.</title>
<authorList>
<person name="Ma C.T."/>
<person name="Velazquez-Dones A."/>
<person name="Hagopian J.C."/>
<person name="Ghosh G."/>
<person name="Fu X.D."/>
<person name="Adams J.A."/>
</authorList>
<dbReference type="PubMed" id="18155240"/>
<dbReference type="DOI" id="10.1016/j.jmb.2007.08.029"/>
</citation>
<scope>PHOSPHORYLATION BY SRPK1</scope>
<scope>THE MECHANISM OF PHOSPHORYLATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="J. Mol. Biol." volume="382" first="894" last="909">
<title>Adaptable molecular interactions guide phosphorylation of the SR protein ASF/SF2 by SRPK1.</title>
<authorList>
<person name="Hagopian J.C."/>
<person name="Ma C.T."/>
<person name="Meade B.R."/>
<person name="Albuquerque C.P."/>
<person name="Ngo J.C."/>
<person name="Ghosh G."/>
<person name="Jennings P.A."/>
<person name="Fu X.D."/>
<person name="Adams J.A."/>
</authorList>
<dbReference type="PubMed" id="18687337"/>
<dbReference type="DOI" id="10.1016/j.jmb.2008.07.055"/>
</citation>
<scope>PHOSPHORYLATION BY SRPK1</scope>
<scope>THE MECHANISM OF PHOSPHORYLATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-199; SER-205; SER-231; SER-234 AND SER-238</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Biochemistry" volume="48" first="11432" last="11440">
<title>Allosteric interactions direct binding and phosphorylation of ASF/SF2 by SRPK1.</title>
<authorList>
<person name="Huynh N."/>
<person name="Ma C.T."/>
<person name="Giang N."/>
<person name="Hagopian J."/>
<person name="Ngo J."/>
<person name="Adams J."/>
<person name="Ghosh G."/>
</authorList>
<dbReference type="PubMed" id="19886675"/>
<dbReference type="DOI" id="10.1021/bi901107q"/>
</citation>
<scope>PHOSPHORYLATION BY SRPK1</scope>
<scope>THE MECHANISM OF PHOSPHORYLATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="J. Mol. Biol." volume="390" first="618" last="634">
<title>Regiospecific phosphorylation control of the SR protein ASF/SF2 by SRPK1.</title>
<authorList>
<person name="Ma C.T."/>
<person name="Hagopian J.C."/>
<person name="Ghosh G."/>
<person name="Fu X.D."/>
<person name="Adams J.A."/>
</authorList>
<dbReference type="PubMed" id="19477182"/>
<dbReference type="DOI" id="10.1016/j.jmb.2009.05.060"/>
</citation>
<scope>PHOSPHORYLATION BY SRPK1</scope>
<scope>THE MECHANISM OF PHOSPHORYLATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="Nat. Biotechnol." volume="27" first="667" last="670">
<title>Rapid and systematic analysis of the RNA recognition specificities of RNA-binding proteins.</title>
<authorList>
<person name="Ray D."/>
<person name="Kazan H."/>
<person name="Chan E.T."/>
<person name="Pena Castillo L."/>
<person name="Chaudhry S."/>
<person name="Talukder S."/>
<person name="Blencowe B.J."/>
<person name="Morris Q."/>
<person name="Hughes T.R."/>
</authorList>
<dbReference type="PubMed" id="19561594"/>
<dbReference type="DOI" id="10.1038/nbt.1550"/>
</citation>
<scope>RNA-BINDING</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-38 AND LYS-179</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="2762" last="2774">
<title>Arginine methylation controls the subcellular localization and functions of the oncoprotein splicing factor SF2/ASF.</title>
<authorList>
<person name="Sinha R."/>
<person name="Allemand E."/>
<person name="Zhang Z."/>
<person name="Karni R."/>
<person name="Myers M.P."/>
<person name="Krainer A.R."/>
</authorList>
<dbReference type="PubMed" id="20308322"/>
<dbReference type="DOI" id="10.1128/mcb.01270-09"/>
</citation>
<scope>METHYLATION AT ARG-93; ARG-97 AND ARG-109</scope>
<scope>MUTAGENESIS OF ARG-93; ARG-97 AND ARG-109</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-199</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="Nucleic Acids Res." volume="39" first="4300" last="4314">
<title>NSrp70 is a novel nuclear speckle-related protein that modulates alternative pre-mRNA splicing in vivo.</title>
<authorList>
<person name="Kim Y.D."/>
<person name="Lee J.Y."/>
<person name="Oh K.M."/>
<person name="Araki M."/>
<person name="Araki K."/>
<person name="Yamamura K.I."/>
<person name="Jun C.D."/>
</authorList>
<dbReference type="PubMed" id="21296756"/>
<dbReference type="DOI" id="10.1093/nar/gkq1267"/>
</citation>
<scope>INTERACTION WITH CCDC55</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2 AND SER-199</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-133; SER-199; SER-201 AND SER-205</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-199; SER-201 AND TYR-202</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-93; ARG-97; ARG-109 AND ARG-111</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2014" name="Oncogene" volume="33" first="1818" last="1827">
<title>RRP1B is a metastasis modifier that regulates the expression of alternative mRNA isoforms through interactions with SRSF1.</title>
<authorList>
<consortium name="NISC Comparative Sequencing Program"/>
<person name="Lee M."/>
<person name="Dworkin A.M."/>
<person name="Gildea D."/>
<person name="Trivedi N.S."/>
<person name="Moorhead G.B."/>
<person name="Crawford N.P."/>
</authorList>
<dbReference type="PubMed" id="23604122"/>
<dbReference type="DOI" id="10.1038/onc.2013.133"/>
</citation>
<scope>INTERACTION WITH RRP1B</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-38</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-30 AND LYS-38</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="46">
<citation type="submission" date="2005-11" db="PDB data bank">
<title>Solution structure of RRM domain in splicing factor SF2.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 1-98</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2008" name="Mol. Cell" volume="29" first="563" last="576">
<title>A sliding docking interaction is essential for sequential and processive phosphorylation of an SR protein by SRPK1.</title>
<authorList>
<person name="Ngo J.C."/>
<person name="Giang K."/>
<person name="Chakrabarti S."/>
<person name="Ma C.T."/>
<person name="Huynh N."/>
<person name="Hagopian J.C."/>
<person name="Dorrestein P.C."/>
<person name="Fu X.D."/>
<person name="Adams J.A."/>
<person name="Ghosh G."/>
</authorList>
<dbReference type="PubMed" id="18342604"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.12.017"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 105-219 IN COMPLEX WITH SRPK1</scope>
<scope>MECHANISM OF ITS PHOSPHORYLATION BY SRPK1</scope>
<scope>DOMAIN RRM</scope>
</reference>
<reference key="48" evidence="6">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="2728" last="2733">
<title>Structural basis for nuclear import of splicing factors by human Transportin 3.</title>
<authorList>
<person name="Maertens G.N."/>
<person name="Cook N.J."/>
<person name="Wang W."/>
<person name="Hare S."/>
<person name="Gupta S.S."/>
<person name="Oztop I."/>
<person name="Lee K."/>
<person name="Pye V.E."/>
<person name="Cosnefroy O."/>
<person name="Snijders A.P."/>
<person name="KewalRamani V.N."/>
<person name="Fassati A."/>
<person name="Engelman A."/>
<person name="Cherepanov P."/>
</authorList>
<dbReference type="PubMed" id="24449914"/>
<dbReference type="DOI" id="10.1073/pnas.1320755111"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.56 ANGSTROMS) OF 106-230 IN COMPLEX WITH TNPO3</scope>
<scope>PHOSPHORYLATION AT SER-201; SER-207 AND SER-209</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] SER-89</scope>
</reference>
<comment type="function">
<text evidence="34">Plays a role in preventing exon skipping, ensuring the accuracy of splicing and regulating alternative splicing. Interacts with other spliceosomal components, via the RS domains, to form a bridge between the 5'- and 3'-splice site binding components, U1 snRNP and U2AF. Can stimulate binding of U1 snRNP to a 5'-splice site-containing pre-mRNA. Binds to purine-rich RNA sequences, either the octamer, 5'-RGAAGAAC-3' (r=A or G) or the decamers, AGGACAGAGC/AGGACGAAGC. Binds preferentially to the 5'-CGAGGCG-3' motif in vitro. Three copies of the octamer constitute a powerful splicing enhancer in vitro, the ASF/SF2 splicing enhancer (ASE) which can specifically activate ASE-dependent splicing. Isoform ASF-2 and isoform ASF-3 act as splicing repressors. May function as export adapter involved in mRNA nuclear export through the TAP/NXF1 pathway.</text>
</comment>
<comment type="subunit">
<text evidence="17 18 20 21 22 25 26 31 32 33 36 37 39 40">Consists of two polypeptides of p32 and p33. In vitro, self-associates and binds SRSF2, SNRNP70 and U2AF1 but not U2AF2. Binds SREK1/SFRS12. Interacts with SAFB/SAFB1. Interacts with PSIP1/LEDGF. Interacts with SRPK1. Identified in the spliceosome C complex. Interacts with RSRC1 (via Arg/Ser-rich domain). Interacts with ZRSR2/U2AF1-RS2. Interacts with CCDC55 (via C-terminus). Interacts with SRPK1 and a sliding docking interaction is essential for its sequential and processive phosphorylation by SRPK1. Interacts with NXF1. Interacts with CCNL1, CCNL2 and CDK11B (PubMed:18216018). Interacts with RRP1B (PubMed:23604122). Interacts (when phosphorylated in its RS domain) with TNPO3; promoting nuclear import (PubMed:24449914).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-398920">
<id>Q07955</id>
</interactant>
<interactant intactId="EBI-627102">
<id>Q86X95</id>
<label>CIR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-398920">
<id>Q07955</id>
</interactant>
<interactant intactId="EBI-11981867">
<id>P49759-3</id>
<label>CLK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-398920">
<id>Q07955</id>
</interactant>
<interactant intactId="EBI-389739">
<id>P23511</id>
<label>NFYA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-398920">
<id>Q07955</id>
</interactant>
<interactant intactId="EBI-398874">
<id>Q9UBU9</id>
<label>NXF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-398920">
<id>Q07955</id>
</interactant>
<interactant intactId="EBI-372051">
<id>Q14684</id>
<label>RRP1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-398920">
<id>Q07955</id>
</interactant>
<interactant intactId="EBI-1049228">
<id>P08621</id>
<label>SNRNP70</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-398920">
<id>Q07955</id>
</interactant>
<interactant intactId="EBI-539478">
<id>Q96SB4</id>
<label>SRPK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-398920">
<id>Q07955</id>
</interactant>
<interactant intactId="EBI-725485">
<id>P62995</id>
<label>TRA2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-398920">
<id>Q07955</id>
</interactant>
<interactant intactId="EBI-523498">
<id>O00463</id>
<label>TRAF5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-398920">
<id>Q07955</id>
</interactant>
<interactant intactId="EBI-632461">
<id>Q01081</id>
<label>U2AF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-398920">
<id>Q07955</id>
</interactant>
<interactant intactId="EBI-593343">
<id>O70551</id>
<label>Srpk1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-398920">
<id>Q07955</id>
</interactant>
<interactant intactId="EBI-593325">
<id>O54781</id>
<label>Srpk2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="19 30 33 38">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19 30 33 38">Nucleus speckle</location>
</subcellularLocation>
<text evidence="19 30 33 38">In nuclear speckles. Shuttles between the nucleus and the cytoplasm (PubMed:12215544, PubMed:20308322, PubMed:9420331, PubMed:24449914). Nuclear import is mediated via interaction with TNPO3 (PubMed:24449914).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q07955-1</id>
<name>ASF-1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q07955-2</id>
<name>ASF-2</name>
<sequence type="described" ref="VSP_005856"/>
</isoform>
<isoform>
<id>Q07955-3</id>
<name>ASF-3</name>
<sequence type="described" ref="VSP_005857 VSP_005858"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="26">The RRM 2 domain plays an important role in governing both the binding mode and the phosphorylation mechanism of the RS domain by SRPK1. RS domain and RRM 2 are uniquely positioned to initiate a highly directional (C-terminus to N-terminus) phosphorylation reaction in which the RS domain slides through an extended electronegative channel separating the docking groove of SRPK1 and the active site. RRM 2 binds toward the periphery of the active site and guides the directional phosphorylation mechanism. Both the RS domain and an RRM domain are required for nucleocytoplasmic shuttling.</text>
</comment>
<comment type="PTM">
<text evidence="21 24 27 28 29">Phosphorylated by CLK1, CLK2, CLK3 and CLK4. Phosphorylated by SRPK1 at multiple serines in its RS domain via a directional (C-terminal to N-terminal) and a dual-track mechanism incorporating both processive phosphorylation (in which the kinase stays attached to the substrate after each round of phosphorylation) and distributive phosphorylation steps (in which the kinase and substrate dissociate after each phosphorylation event). The RS domain of SRSF1 binds to a docking groove in the large lobe of the kinase domain of SRPK1 and this induces certain structural changes in SRPK1 and/or RRM 2 domain of SRSF1, allowing RRM 2 to bind the kinase and initiate phosphorylation. The cycles continue for several phosphorylation steps in a processive manner (steps 1-8) until the last few phosphorylation steps (approximately steps 9-12). During that time, a mechanical stress induces the unfolding of the beta-4 motif in RRM 2, which then docks at the docking groove of SRPK1. This also signals RRM 2 to begin to dissociate, which facilitates SRSF1 dissociation after phosphorylation is completed.</text>
</comment>
<comment type="PTM">
<text evidence="30">Asymmetrically dimethylated at arginines, probably by PRMT1, methylation promotes localization to nuclear speckles.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform ASF-3</molecule>
<text evidence="43">May be due to intron retention.</text>
</comment>
<comment type="similarity">
<text evidence="43">Belongs to the splicing factor SR family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/SRSF1ID47631ch17q22.html"/>
</comment>
<dbReference type="EMBL" id="M72709">
<property type="protein sequence ID" value="AAA35565.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M72709">
<property type="protein sequence ID" value="AAA35564.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M69040">
<property type="protein sequence ID" value="AAA03476.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB062124">
<property type="protein sequence ID" value="BAB93456.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK312781">
<property type="protein sequence ID" value="BAG35644.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471109">
<property type="protein sequence ID" value="EAW94485.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471109">
<property type="protein sequence ID" value="EAW94486.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC010264">
<property type="protein sequence ID" value="AAH10264.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC033785">
<property type="protein sequence ID" value="AAH33785.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11600.1">
<molecule id="Q07955-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58580.1">
<molecule id="Q07955-3"/>
</dbReference>
<dbReference type="PIR" id="A40040">
<property type="entry name" value="A40040"/>
</dbReference>
<dbReference type="PIR" id="B40040">
<property type="entry name" value="B40040"/>
</dbReference>
<dbReference type="PIR" id="C40040">
<property type="entry name" value="C40040"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001071634.1">
<molecule id="Q07955-3"/>
<property type="nucleotide sequence ID" value="NM_001078166.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_008855.1">
<molecule id="Q07955-1"/>
<property type="nucleotide sequence ID" value="NM_006924.4"/>
</dbReference>
<dbReference type="PDB" id="1X4A">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-96"/>
</dbReference>
<dbReference type="PDB" id="2M7S">
<property type="method" value="NMR"/>
<property type="chains" value="A=106-195"/>
</dbReference>
<dbReference type="PDB" id="2M8D">
<property type="method" value="NMR"/>
<property type="chains" value="B=107-196"/>
</dbReference>
<dbReference type="PDB" id="2O3D">
<property type="method" value="NMR"/>
<property type="chains" value="A=107-215"/>
</dbReference>
<dbReference type="PDB" id="3BEG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="B=105-219"/>
</dbReference>
<dbReference type="PDB" id="4C0O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.56"/>
<property type="chains" value="C/D=106-230"/>
</dbReference>
<dbReference type="PDBsum" id="1X4A"/>
<dbReference type="PDBsum" id="2M7S"/>
<dbReference type="PDBsum" id="2M8D"/>
<dbReference type="PDBsum" id="2O3D"/>
<dbReference type="PDBsum" id="3BEG"/>
<dbReference type="PDBsum" id="4C0O"/>
<dbReference type="BMRB" id="Q07955"/>
<dbReference type="SMR" id="Q07955"/>
<dbReference type="BioGRID" id="112324">
<property type="interactions" value="227"/>
</dbReference>
<dbReference type="CORUM" id="Q07955"/>
<dbReference type="DIP" id="DIP-2155N"/>
<dbReference type="IntAct" id="Q07955">
<property type="interactions" value="97"/>
</dbReference>
<dbReference type="MINT" id="Q07955"/>
<dbReference type="STRING" id="9606.ENSP00000258962"/>
<dbReference type="ChEMBL" id="CHEMBL4295805"/>
<dbReference type="DrugBank" id="DB09130">
<property type="generic name" value="Copper"/>
</dbReference>
<dbReference type="iPTMnet" id="Q07955"/>
<dbReference type="PhosphoSitePlus" id="Q07955"/>
<dbReference type="SwissPalm" id="Q07955"/>
<dbReference type="BioMuta" id="SRSF1"/>
<dbReference type="DMDM" id="730773"/>
<dbReference type="EPD" id="Q07955"/>
<dbReference type="jPOST" id="Q07955"/>
<dbReference type="MassIVE" id="Q07955"/>
<dbReference type="MaxQB" id="Q07955"/>
<dbReference type="PaxDb" id="Q07955"/>
<dbReference type="PeptideAtlas" id="Q07955"/>
<dbReference type="PRIDE" id="Q07955"/>
<dbReference type="ProteomicsDB" id="58560">
<molecule id="Q07955-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58561">
<molecule id="Q07955-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58562">
<molecule id="Q07955-3"/>
</dbReference>
<dbReference type="TopDownProteomics" id="Q07955-1">
<molecule id="Q07955-1"/>
</dbReference>
<dbReference type="TopDownProteomics" id="Q07955-2">
<molecule id="Q07955-2"/>
</dbReference>
<dbReference type="TopDownProteomics" id="Q07955-3">
<molecule id="Q07955-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="4585">
<property type="antibodies" value="296 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="6426"/>
<dbReference type="Ensembl" id="ENST00000258962">
<molecule id="Q07955-1"/>
<property type="protein sequence ID" value="ENSP00000258962"/>
<property type="gene ID" value="ENSG00000136450"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000581979">
<molecule id="Q07955-3"/>
<property type="protein sequence ID" value="ENSP00000463223"/>
<property type="gene ID" value="ENSG00000136450"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000582730">
<molecule id="Q07955-3"/>
<property type="protein sequence ID" value="ENSP00000462215"/>
<property type="gene ID" value="ENSG00000136450"/>
</dbReference>
<dbReference type="GeneID" id="6426"/>
<dbReference type="KEGG" id="hsa:6426"/>
<dbReference type="UCSC" id="uc002ivi.4">
<molecule id="Q07955-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6426"/>
<dbReference type="DisGeNET" id="6426"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000136450.12"/>
<dbReference type="GeneCards" id="SRSF1"/>
<dbReference type="HGNC" id="HGNC:10780">
<property type="gene designation" value="SRSF1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000136450">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="600812">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q07955"/>
<dbReference type="OpenTargets" id="ENSG00000136450"/>
<dbReference type="PharmGKB" id="PA35696"/>
<dbReference type="eggNOG" id="KOG0105">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155585"/>
<dbReference type="HOGENOM" id="CLU_012062_34_5_1"/>
<dbReference type="InParanoid" id="Q07955"/>
<dbReference type="KO" id="K12890"/>
<dbReference type="OrthoDB" id="1321443at2759"/>
<dbReference type="PhylomeDB" id="Q07955"/>
<dbReference type="TreeFam" id="TF106261"/>
<dbReference type="PathwayCommons" id="Q07955"/>
<dbReference type="Reactome" id="R-HSA-159236">
<property type="pathway name" value="Transport of Mature mRNA derived from an Intron-Containing Transcript"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-72163">
<property type="pathway name" value="mRNA Splicing - Major Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-72165">
<property type="pathway name" value="mRNA Splicing - Minor Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-72187">
<property type="pathway name" value="mRNA 3'-end processing"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73856">
<property type="pathway name" value="RNA Polymerase II Transcription Termination"/>
</dbReference>
<dbReference type="SIGNOR" id="Q07955"/>
<dbReference type="BioGRID-ORCS" id="6426">
<property type="hits" value="757 hits in 880 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SRSF1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q07955"/>
<dbReference type="GeneWiki" id="ASF/SF2"/>
<dbReference type="GenomeRNAi" id="6426"/>
<dbReference type="Pharos" id="Q07955">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q07955"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="RNAct" id="Q07955">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000136450">
<property type="expression patterns" value="Expressed in oviduct epithelium and 252 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q07955">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q07955">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0071013">
<property type="term" value="C:catalytic step 2 spliceosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044547">
<property type="term" value="F:DNA topoisomerase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0003729">
<property type="term" value="F:mRNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000380">
<property type="term" value="P:alternative mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031124">
<property type="term" value="P:mRNA 3'-end processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000395">
<property type="term" value="P:mRNA 5'-splice site recognition"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045292">
<property type="term" value="P:mRNA cis splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006406">
<property type="term" value="P:mRNA export from nucleus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006397">
<property type="term" value="P:mRNA processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006376">
<property type="term" value="P:mRNA splice site selection"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0000398">
<property type="term" value="P:mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000381">
<property type="term" value="P:regulation of alternative mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006405">
<property type="term" value="P:RNA export from nucleus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="CDD" id="cd12597">
<property type="entry name" value="RRM1_SRSF1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="DisProt" id="DP01641"/>
<dbReference type="Gene3D" id="3.30.70.330">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR012677">
<property type="entry name" value="Nucleotide-bd_a/b_plait_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR035979">
<property type="entry name" value="RBD_domain_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000504">
<property type="entry name" value="RRM_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR029538">
<property type="entry name" value="SRSF1"/>
</dbReference>
<dbReference type="InterPro" id="IPR034520">
<property type="entry name" value="SRSF1_RRM1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR23147:SF44">
<property type="entry name" value="PTHR23147:SF44"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00076">
<property type="entry name" value="RRM_1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00360">
<property type="entry name" value="RRM"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54928">
<property type="entry name" value="SSF54928"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50102">
<property type="entry name" value="RRM"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0507">mRNA processing</keyword>
<keyword id="KW-0508">mRNA splicing</keyword>
<keyword id="KW-0509">mRNA transport</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0747">Spliceosome</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="10">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Serine/arginine-rich splicing factor 1" id="PRO_0000081911">
<location>
<begin position="2"/>
<end position="248"/>
</location>
</feature>
<feature type="domain" description="RRM 1" evidence="16">
<location>
<begin position="16"/>
<end position="91"/>
</location>
</feature>
<feature type="domain" description="RRM 2" evidence="16">
<location>
<begin position="121"/>
<end position="195"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SAFB1">
<location>
<begin position="198"/>
<end position="247"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gly-rich (hinge region)">
<location>
<begin position="94"/>
<end position="113"/>
</location>
</feature>
<feature type="compositionally biased region" description="Arg/Ser-rich (RS domain)">
<location>
<begin position="198"/>
<end position="247"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="10">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="8">
<location>
<position position="38"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="30">
<location>
<position position="93"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="12">
<location>
<position position="93"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="30">
<location>
<position position="97"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="12">
<location>
<position position="97"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="30">
<location>
<position position="109"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="12">
<location>
<position position="109"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="12">
<location>
<position position="111"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="133"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="8">
<location>
<position position="179"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 9 10 11 13">
<location>
<position position="199"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 13 33">
<location>
<position position="201"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="13">
<location>
<position position="202"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 11">
<location>
<position position="205"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="33">
<location>
<position position="207"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="33">
<location>
<position position="209"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="231"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="234"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="238"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="15">
<location>
<position position="30"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="14 15">
<location>
<position position="38"/>
</location>
</feature>
<feature type="splice variant" description="In isoform ASF-2." id="VSP_005856" evidence="42">
<original>GETAYIRVKVDGPRSPSYGRSRSRSRSRSRSRSRSNSRSRSYSPRRSRGSPRYSPRHSRSRSRT</original>
<variation>FCLSNREKLPTSGLKLMGPEVQVMEDLDLEAVVVAEAVAEATAGVAVTPQGEAEDHHAILPVIADLALVHKMIGDTFCRTHVVYSFPLFSTIFSFFNSNCFVQNGLKC</variation>
<location>
<begin position="185"/>
<end position="248"/>
</location>
</feature>
<feature type="splice variant" description="In isoform ASF-3." id="VSP_005857" evidence="41">
<original>GETAYIRVKVDGPRSPS</original>
<variation>VGYTRILFFDQNWIQWS</variation>
<location>
<begin position="185"/>
<end position="201"/>
</location>
</feature>
<feature type="splice variant" description="In isoform ASF-3." id="VSP_005858" evidence="41">
<location>
<begin position="202"/>
<end position="248"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_035488" evidence="23">
<original>P</original>
<variation>S</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="mutagenesis site" description="In FV1; loss of ability to activate splicing. Slight reduction in splice site switching activity and no effect on RNA-binding." evidence="35">
<original>FV</original>
<variation>SR</variation>
<location>
<begin position="58"/>
<end position="59"/>
</location>
</feature>
<feature type="mutagenesis site" description="Predominantly localizes to cytoplasm and fails to modulate splicing of endogenous pre-mRNAs; when associated with Ala-97 and Ala-109." evidence="30">
<original>R</original>
<variation>A</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="mutagenesis site" description="Predominantly localizes to cytoplasm and fails to modulate splicing of endogenous pre-mRNAs; when associated with Ala-93 and Ala-109." evidence="30">
<original>R</original>
<variation>A</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="mutagenesis site" description="Predominantly localizes to cytoplasm and fails to modulate splicing of endogenous pre-mRNAs; when associated with Ala-93 and Ala-97." evidence="30">
<original>R</original>
<variation>A</variation>
<location>
<position position="109"/>
</location>
</feature>
<feature type="mutagenesis site" description="In FV2; loss of ability to activate splicing. Great reduction in splice site switching activity and RNA-binding." evidence="35">
<original>FV</original>
<variation>SR</variation>
<location>
<begin position="162"/>
<end position="163"/>
</location>
</feature>
<feature type="mutagenesis site" description="In AV; loss of ability to activate splicing. Great reduction in splice site switching activity and no effect on RNA-binding." evidence="38">
<original>F</original>
<variation>A</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced nucleocytoplasmic shuttling; when associated with D-190." evidence="38">
<original>F</original>
<variation>D</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced nucleocytoplasmic shuttling; when associated with D-162." evidence="38">
<original>F</original>
<variation>D</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="mutagenesis site" description="In MR-B; strongly inhibits splicing." evidence="35">
<location>
<begin position="182"/>
<end position="248"/>
</location>
</feature>
<feature type="mutagenesis site" description="In MR-E; loss of ability to activate splicing." evidence="35">
<location>
<begin position="182"/>
<end position="199"/>
</location>
</feature>
<feature type="mutagenesis site" description="In MR-A; loss of ability to activate splicing." evidence="35">
<location>
<begin position="192"/>
<end position="248"/>
</location>
</feature>
<feature type="mutagenesis site" description="In MR-D; loss of ability to activate splicing." evidence="35">
<location>
<begin position="192"/>
<end position="199"/>
</location>
</feature>
<feature type="mutagenesis site" description="In RS-A; loss of ability to activate splicing but retains splice site switching." evidence="35">
<location>
<begin position="199"/>
<end position="224"/>
</location>
</feature>
<feature type="mutagenesis site" description="In RS-C; loss of ability to activate splicing but retains splice site switching." evidence="35">
<location>
<begin position="215"/>
<end position="248"/>
</location>
</feature>
<feature type="mutagenesis site" description="In RS-B; retains both splice activation and splice site switching activity." evidence="35">
<location>
<begin position="226"/>
<end position="248"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="15"/>
<end position="22"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="29"/>
<end position="36"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="37"/>
<end position="39"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="42"/>
<end position="47"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="50"/>
<end position="54"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="57"/>
<end position="62"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="64"/>
<end position="74"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="85"/>
<end position="87"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="110"/>
<end position="113"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="122"/>
<end position="127"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="134"/>
<end position="141"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="142"/>
<end position="144"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="147"/>
<end position="152"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="158"/>
<end position="164"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="165"/>
<end position="174"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="175"/>
<end position="177"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="179"/>
<end position="181"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="183"/>
<end position="185"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="187"/>
<end position="189"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="191"/>
<end position="197"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="202"/>
<end position="204"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="206"/>
<end position="208"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1X4A"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2M7S"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2M8D"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2O3D"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3BEG"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4C0O"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00176"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10757789"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11991638"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12215544"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12667464"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14555757"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15798186"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18155240"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18216018"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18342604"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18687337"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19477182"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19886675"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20308322"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21296756"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23604122"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24449914"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8139654"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8223481"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8261509"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9237760"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9420331"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9671816"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9885563"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1855257"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000305"/>
<sequence length="248" mass="27745" checksum="C28A0B2F112EA713" modified="2007-01-23" version="2">MSGGGVIRGPAGNNDCRIYVGNLPPDIRTKDIEDVFYKYGAIRDIDLKNRRGGPPFAFVEFEDPRDAEDAVYGRDGYDYDGYRLRVEFPRSGRGTGRGGGGGGGGGAPRGRYGPPSRRSENRVVVSGLPPSGSWQDLKDHMREAGDVCYADVYRDGTGVVEFVRKEDMTYAVRKLDNTKFRSHEGETAYIRVKVDGPRSPSYGRSRSRSRSRSRSRSRSNSRSRSYSPRRSRGSPRYSPRHSRSRSRT</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

